Processa Pharmaceuticals prices public offering at $0.615 per share

From GlobeNewswire: 2025-01-27 20:30:00

Processa Pharmaceuticals, Inc. has announced a public offering of 8,050,672 shares of common stock at a price of $0.615 per share for institutional investors and $0.7975 for certain board members. The offering is expected to raise $5 million and is set to close on January 29, 2025. Processa plans to seek stockholder approval for the issuance of shares upon exercise of warrants. A.G.P./Alliance Global Partners is the sole placement agent for the offering. The registration statement for the offering was declared effective by the SEC on January 27, 2025.

Processa Pharmaceuticals, Inc. is a clinical-stage pharmaceutical company focused on developing Next Generation Chemotherapy drugs for cancer treatment. Their drugs are modifications of existing FDA-approved oncology therapies to improve safety and efficacy. The company’s strategy is to develop more effective therapy options for cancer patients through an efficient regulatory path. For more information, visit their website at www.processapharma.com.



Read more at GlobeNewswire: Processa Pharmaceuticals Announces Pricing of $5 Million